Disease D004194

Description

A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.   MeSH

Hierarchy View

Subtype Terms (1)

Syndrome
3 drugs (2 approved, 1 experimental)


Approved Indicated Drugs (1)

Phase 3 Indicated Drugs (3)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (279)

Aarhus University

Abbott

Actavis

Ajou University

Albany Medical College

Alkermes

Allegheny Health Network

All India Institute of Medical Sciences

AMAG Pharmaceuticals, Inc.

American Academy of Child Adolescent Psychiatry.

American Epilepsy Society

American Psychiatric Association

APG Research

Association Francaise pour la Recherche Thermale

Astellas

AstraZeneca

Augusta University

Azur Pharma, Inc

Baylor University

Beer Yaakov and Ness Ziona Mental Health Center

Beijing CAT Science Co., Ltd.

Bio Products Laboratory

Boehringer Ingelheim

Brain & Behavior Research Foundation

Brainclinics Diagnostics B.V.

Brain Dynamics Centre

BRC Operations Pty. Ltd.

Bristol-Myers Squibb

Brown University

Case Western Reserve University

Catholic University of Korea

Cedars-Sinai Medical Center

Central South University

Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec

Centre Hospitalier Henri Laborit

Cephalon

Chang Gung University

Charles University

Child and adolescent Psychiatric department, South Jutland

Children's Medical Center Dallas

Children's Specialized Hospital

Chinese Academy of Medical Sciences

Chulalongkorn University

CJ HealthCare Corp.

Columbia University

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Corning Hospital, Shenzhen City

Creighton University

CSL Behring

Dartmouth University

Demarest Lloyd Jr. Foundation

Department of Health and Human Services

Department of Veteran Affairs

Douglas Sears

Duke University

Eli Lilly

Emory University

Epilepsy Foundation

Erzurum Regional Training & Research Hospital

Federal University of Rio de Janeiro

Federal University of Rio Grande do Sul

Flinders University

Food and Drug Administration

Forest Laboratories

FPC De Kijvelanden

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fund for Advancement of Medical Science

Georgetown University

GlaxoSmithKline

Government of Denmark

Government of Pakistan

Government of Taiwan

GTO Pharmaceutical, LLC

Guangzhou Medical University

Guangzhou University

Hamilton Health Sciences Corporation

Hangzhou Seventh People's Hospital

Harvard University

Hassman Research Institute

Honda

Hoosier Cancer Research Network

Horizon Pharma

Horizon Therapeutics, LLC

Howard University

Huazhong University of Science and Technology

Icahn School of Medicine at Mount Sinai

IMMUNOe

Imperial College London

Indiana University

Indivior Inc.

Ipsen

Isaac Melamed

Istituto di Neuroscienze

Janssen Pharmaceutica NV

JayMac Pharmaceuticals, LLC

Jerusalem Mental Health Center

Jiangsu University

Jiao Tong University

Jinan University

Johns Hopkins University

Johnson and Johnson

JPM van Stralen Medicine Professional

Katholieke Universiteit Leuven

Kunming Medical University

Lawson, William B., M.D., PhD, DFAPA

Leiden University

Les thermes de Saujon

LinkDoc Technology (Beijing) Co. Ltd.

Loyola University

Ludwig Maximilians University

Lundbeck

Maastricht University

Manhattan Psychiatric Center

Massachusetts Institute of Technology

Mater Mothers' Hospital

Mayo Clinic

McGill University

Mclean Hospital

McMaster University

McNeil

Medical Center Haaglanden

Medical College of Wisconsin

Medical University of South Carolina

Melbourne Health

Merck

Michael J. Fox Foundation for Parkinson's Research

Michael J. Gill Mental Health Clinic

Monarch Medical Research

Monash University

Mountain States Regional Hemophilia Center, Aurora, Columbia

Mundipharma

Nanjing Medical University

National Cheng Kung University

National Health and Medical Research Council, Australia

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

New York MDRU

New York University

North Suffolk Mental Health Association

Northwell Health

Novartis

Ohio State University

Osaka City University

Otsuka

Palo Alto Veterans Institute for Research

Parkinson's Disease and Movement Disorders Center

Patient-Centered Outcomes Research Institute

Peking University

People's Liberation Army of China

Pfizer

Policlinique Médicale Universitaire

Psych Care Consultants Research

Purdue Pharmaceuticals

Queen's University, Belfast

RAND Corporation

Red Oak Psychiatry

Region of Southern Denmark

Region Syddanmark

Region Västmanland

Rhode Island Hospital

Roche

Rutgers University

Sears, Douglas, M.D.

Second Military Medical University

Seoul National University

Servier

Shaanxi Buchang Pharmaceutical Co., Ltd

Sha'ar Menashe Mental Health Center

Shandong Mental Health Center

Shanghai Municipal Science and Technology Commission

Shanghai University of Traditional Chinese Medicine

Shanti Clinical Trials

Shanxi Medical University

Shire

Skyland Behavioral Health Associates

Soochow University

South Australian Health and Medical Research Institute

Stanford University

Stanley Medical Research Institute

State University of New York

State University of New York, Syracuse

Stellenbosch University

St. Luke's-Roosevelt Hospital Center

Stony Brook University

Sumitomo

Sungkyunkwan University

Sunovion

Sun Yat-Sen University

Supernus Pharmaceuticals

Swinburne University

Taipei Veteran General hospital

Takeda

Technical University of Munich

Technion University

Tel Aviv University

The Alfred Hospital

The Dana Foundation

the First Specialized Subject Hospital of Harbin

The Massachusetts Mental Health Center

The Medical Research Network, LLC

The University of Hong Kong

The University of Texas, Dallas

The Zucker Hillside Hospital

Thomas Jefferson University

Tsinghua University

Tufts University

Tuscaloosa Research & Education Advancement Corporation (TREAC)

Universidad Autonoma de Madrid

Universidade Estadual de Londrina

Universidade Estadual de Maringá

Universidad Nacional de Rosario

University of Adelaide

University of Antwerp

University of Arizona

University of Barcelona

University of Buenos Aires

University of California, Berkeley

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Chicago

University of Cincinnati

University of Colorado, Denver

University of Connecticut

University of Copenhagen

University of Florence

University of Florida

University of Georgia

University of Ghana

University of Goettingen

University of Gothenburg

University of Heidelberg

University of Kansas

University of Lausanne

University of London

University of Manchester

University of Maryland

University of Massachusetts

University of Medicine and Dentistry of New Jersey

University of Melbourne

University of Miami

University of Michigan

University of Missouri, Kansas City

University of Nebraska

University of New Mexico

University of North Carolina at Chapel Hill

University of Pennsylvania

University of Pisa

University of Pittsburgh

University of Poitiers

University of Queensland

University of Rochester

University of Sao Paulo

University of South Carolina

University of Southern Denmark

University of South Florida

University of Sydney

University of Texas, San Antonio

University of Toronto

University of Toulouse

University of Vienna

University of Washington

University of Western Ontario

Utrecht University

Validus Pharmaceuticals

Vanderbilt University

Vastra Gotaland Region

Veterans Medical Research Foundation

Washington University in St. Louis

Wenzhou Medical University

West Coast College of Biological Psychiatry

Wuhan University

Yale University

Yeshiva University

Zhejiang University

Ziekenhuis Oost-Limburg

Organization Involved with Phase 3 Indications (159)

Organization Involved with Phase 2 Indications (198)

Organization Involved with Phase 1 Indications (63)

Organization Involved with Other Experimental Indications (71)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.